Article Details

GT Biopharma Reports Fourth Quarter and Year End 2020 Results and Business Update

Retrieved on: 2021-04-19 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

GT Biopharma Reports Fourth Quarter and Year End 2020 Results and Business Update. View article details on hiswai:

Excerpt

GT Biopharma's agreement with Cytovance was further expanded in February 2021 for the manufacturing of all TriKE™ products. Subsequent Event:.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo